James F. Rooney

Also affiliated with National Institutes of Health, Harvard University, Hvidovre Hospital, Rigshospitalet, Public Health Department, National Institute of Neurological Disorders and Stroke, Gilead Sciences (United States), Centre of Excellence for Health, Immunity and Infections

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.744Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment–Experienced People Living With Human Immunodeficiency Virus

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1878

Top 27%

0.744DataRank

Top 27%22 citations

Lene Ryom, Bastian Neesgaard, Gilles Wandeler, Thérèse Staub, Martin Gisinger +68 more

Papers

Driven by 41 papers — median percentile 73. Top paper: “Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women”.

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

New England Journal of Medicine(2021)10.1056/nejmoa2101016

N/A

8.3DataRank · unranked

869 citations

Deborah Donnell, Meredith E. Clement, Brett Hanscom, Leslie Cottle, Lara E. Coelho +60 more

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

The Lancet(2022)10.1016/s0140-6736(22)00538-4

N/A

7.4DataRank · unranked

552 citations

James P. Hughes, Peter Bock, Samuel Gurrion Ouma, Portia Hunidzarira, Dishiki Kalonji +95 more

Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study

The Lancet HIV(2020)10.1016/s2352-3018(19)30433-3

N/A

6.4DataRank · unranked

162 citations

Edwin D. Charlebois, James Ayieko, Dalsone Kwarisiima, Jane Kabami, Laura B. Balzer +24 more

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

The Lancet(2021)10.1016/s0140-6736(21)00314-7

N/A

5.5DataRank · unranked

162 citations

Sean S. Brummel, Lauren Ziemba, Lynda Stranix‐Chibanda, Katie McCarthy, Anne Coletti +39 more

PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial

PLoS Medicine(2021)10.1371/journal.pmed.1003670

N/A

4.7DataRank · unranked

180 citations

Sybil Hosek, Mandisa Tsholwana, Sheetal Kassim, Shorai Mukaka, Bonnie J. Dye +17 more

Tenofovir Diphosphate Concentrations in Dried Blood Spots From Pregnant and Postpartum Adolescent and Young Women Receiving Daily Observed Pre-exposure Prophylaxis in Sub-Saharan Africa

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1872

N/A

2.5DataRank · unranked

63 citations

Peter L. Anderson, Deborah Kacanek, Sybil Hosek, Sharon Huang, Teacler Nematadzira +32 more

Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00261-8

N/A

2.0DataRank · unranked

68 citations

Brett Hanscom, Meredith E. Clement, Trần Việt Hà, Esper G. Kallás, Manya Magnus +25 more

Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: an open-label single-arm phase 2 trial

The Lancet Child & Adolescent Health(2020)10.1016/s2352-4642(20)30248-0

N/A

1.9DataRank · unranked

66 citations

Leigh F. Johnson, Janan Dietrich, Landon Myer, Rebecca Marcus, Melissa Wallace +13 more

Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00227-8

N/A

1.8DataRank · unranked

62 citations

Connie Celum, Daniel Szydlo, Elizabeth R. Brown, Carolyne A. Akello, Rita Nakalega +28 more

Safety and Pharmacokinetics of a Tenofovir Alafenamide Fumarate-Emtricitabine based Oral Antiretroviral Regimen for Prevention of HIV Acquisition in Women: A Randomized Controlled Trial

EClinicalMedicine(2021)10.1016/j.eclinm.2021.100893

N/A

1.7DataRank · unranked

47 citations

Jill L. Schwartz, Mackenzie L. Cottrell, Vivian Brache, Beatrice A. Chen, Leila Cochón +6 more

Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00061-9

N/A

1.1DataRank · unranked

30 citations

Lauren Ziemba, Sean S. Brummel, Katie McCarthy, Anne Coletti, Chelsea Krotje +95 more

Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment–Experienced People Living With Human Immunodeficiency Virus

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1878

Top 27%

0.744DataRank

Top 27%22 citations

Lene Ryom, Bastian Neesgaard, Gilles Wandeler, Thérèse Staub, Martin Gisinger +68 more

Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00200-x

N/A

0.580DataRank · unranked

14 citations

Brett Hanscom, Zhe Wang, Steven A. Safren, Christina Psaros, Deborah Donnell +61 more

Novel Criteria for Diagnosing Acute and Early Human Immunodeficiency Virus Infection in a Multinational Study of Early Antiretroviral Therapy Initiation

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1893

N/A

0.556DataRank · unranked

14 citations

Justin Ritz, Robert W. Coombs, Lu Zheng, Joseph J. Eron, John W. Mellors +31 more

Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.00053-23

N/A

0.510DataRank · unranked

29 citations

Jessica M. Fogel, Zhe Wang, Estelle Piwowar‐Manning, Ryan Kofron, Amber Moser +24 more

HPTN 083‐02: factors influencing adherence to injectable PrEP and retention in an injectable PrEP study

Journal of the International AIDS Society(2024)10.1002/jia2.26252

N/A

0.417DataRank · unranked

9 citations

Georgia R. Goodman, Jasper S. Lee, Whitney S. Rice, Colleen F. Kelley, Temitope Oyedele +18 more

Safety outcomes among infants whose mothers used the dapivirine vaginal ring or oral PrEP during pregnancy (MTN-042/DELIVER): a randomised phase 3b study

The Lancet HIV(2025)10.1016/s2352-3018(25)00261-9

N/A

0.208DataRank · unranked

3 citations

Daniel Szydlo, Ashley Mayo, Katie Bunge, Felix Mhlanga, Jeanna Piper +57 more

Pharmacologic evaluation of delayed long-acting cabotegravir administration among cisgender women in HPTN 084

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.00994-24

N/A

0.165DataRank · unranked

2 citations

Kelong Han, Brett Hanscom, Xu Guo, Estelle Piwowar-Manning, Craig W. Hendrix +14 more

Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial

UNC Libraries(2025)10.17615/8yt1-yt24

N/A

0.104DataRank · unranked

1 citations

Beatriz Grinsztejn, Omar Sued, Adeola Adeyeye, Estelle Piwowar‐Manning, Meredith E. Clement +26 more

Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial

UNC Libraries(2025)10.17615/617b-mq21

N/A

0DataRank · unranked

0 citations

Cecilia Kanyama, Lu Zheng, Joseph J. Eron, Javier R. Lama, Justin Ritz +22 more

Use of DNA profiling to resolve HIV status in a person using injectable cabotegravir for HIV pre-exposure prophylaxis

Journal of Clinical Pathology(2025)10.1136/jcp-2025-210202

N/A

0DataRank · unranked

0 citations

Mahdi Salih, Kathy Haddaway, Mark A. Marzinke, Christi E. Marshall, Zhe Wang +8 more

Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083

Open Forum Infectious Diseases(2025)10.1093/ofid/ofaf645

N/A

0DataRank · unranked

0 citations

Jessica M. Fogel, Mark A. Marzinke, Elias K. Halvas, Urvi M. Parikh, John W. Mellors +15 more

Evaluation of pharmacokinetic interactions between long‐acting cabotegravir or emtricitabine/tenofovir disoproxil fumarate and hormonal contraceptive agents: a tertiary analysis of South African participants in HPTN 084

Journal of the International AIDS Society(2025)10.1002/jia2.70056

N/A

0DataRank · unranked

0 citations

Brett Hanscom, Daniel Haines, Kimberly K. Scarsi, Yaw Agyei, Estelle Piwowar‐Manning +17 more

Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant

Pharmaceutics(2020)10.3390/pharmaceutics12100981

N/A

0DataRank · unranked

105 citations

Nicola Di Trani, Antons Sizovs, Kathryn A. Shelton, Zoha Momin, Lane R. Bushman +13 more

Multi-stakeholder consensus on a target product profile for an HIV cure

The Lancet HIV(2020)10.1016/s2352-3018(20)30234-4

N/A

0DataRank · unranked

79 citations

Timothy Attoye, Cathy Bansbach, Brian Doehle, Karine Dubé, Mark Dybul +15 more

Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)

eScholarship (California Digital Library)(2020)10.17615/m2r7-rg29

N/A

0DataRank · unranked

28 citations

Ian Frank, Susan H. Eshleman, Ken Ho, Robert A. Salata, Jorge Santana +24 more

Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.13.091694

N/A

0DataRank · unranked

17 citations

Antons Sizovs, Kathryn A. Shelton, Zoha Momin, Lane R. Bushman, Jiaqiong Xu +13 more

The Pharmacokinetics and Viral Activity of Tenofovir in the Male Genital Tract

UNC Libraries(2020)10.17615/0qf4-1n75

N/A

0DataRank · unranked

0 citations

Ya‐Chi Chen, Susan A. Fiscus, James F. Rooney, Naser L. Rezk, Angela D. M. Kashuba +6 more

Pharmacokinetics and Safety of Single-Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1-Infected Pregnant Women and Their Infants

UNC Libraries(2020)10.17615/dqr7-0g70

N/A

0DataRank · unranked

0 citations

Patrick Jean‐Philippe, Lynne Mofenson, James F. Rooney, Jack Rodman, Edwin Thorpe +13 more

Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study

UNC Libraries(2020)10.17615/14ka-fe90

N/A

0DataRank · unranked

0 citations

Todd T. Brown, Aleshia Thomas, Joseph J. Eron, Athe Tsibris, Andrea Weiss +82 more

Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab152

N/A

0DataRank · unranked

132 citations

Beatriz Grinsztejn, Jessica M. Fogel, Estelle Piwowar‐Manning, Maoji Li, Lei Weng +25 more

Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab576

N/A

0DataRank · unranked

69 citations

Jessica M. Fogel, Estelle Piwowar‐Manning, Gordon Chau, Vanessa Cummings, Yaw Agyei +28 more

HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac415

N/A

0DataRank · unranked

36 citations

Jessica M. Fogel, Elias K. Halvas, Estelle Piwowar‐Manning, Mark A. Marzinke, Ryan Kofron +25 more

Interaction of Depot Medroxyprogesterone Acetate and Tenofovir Disoproxil Fumarate/Emtricitabine on Peripheral Blood Mononuclear Cells and Cervical Tissue Susceptibility to HIV Infection and Pharmacokinetics

JAIDS Journal of Acquired Immune Deficiency Syndromes(2022)10.1097/qai.0000000000003113

N/A

0DataRank · unranked

4 citations

Clarissa P. Diniz, Edward J. Fuchs, Mark A. Marzinke, Wutyi Aung, Rahul P. Bakshi +10 more

Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis

New England Journal of Medicine(2024)10.1056/nejmc2402088

N/A

0DataRank · unranked

35 citations

Sinéad Delany‐Moretlwe, Jessica M. Fogel, Mark A. Marzinke, Estelle Piwowar-Manning, Paul A. Richardson +15 more

Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial

AIDS(2024)10.1097/qad.0000000000003881

N/A

0DataRank · unranked

18 citations

Justin Ritz, Lu Zheng, Asma Naqvi, Joshua C. Cyktor, Joseph Puleo +21 more

Evaluation of Xpert point-of-care assays for detection of HIV infection in persons using long-acting cabotegravir for pre-exposure prophylaxis

Microbiology Spectrum(2024)10.1128/spectrum.00307-24

N/A

0DataRank · unranked

9 citations

Estelle Piwowar-Manning, Amber Moser, Tinia Hill, Shahnaz Ahmed, Vanessa Cummings +15 more

HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084

AIDS Research and Human Retroviruses(2024)10.1089/aid.2024.0049

N/A

0DataRank · unranked

5 citations

Deborah Persaud, Estelle Piwowar‐Manning, Paul Richardson, Joseph Szewczyk, Mark A. Marzinke +19 more

Evaluation of long‐acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084

Journal of the International AIDS Society(2025)10.1002/jia2.26401

N/A

0DataRank · unranked

17 citations

Brett Hanscom, Xu Guo, Clemensia Nkabiito, Patricia Mandima, Patricia Ntege Nahirya +17 more

Estimation of Prevention-Effective CAB-LA Concentrations Among Men Who Have Sex With Men (MSM) and Transgender Women (TGW) in HPTN 083

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf561

N/A

0DataRank · unranked

2 citations

Mark A. Marzinke, Xinnong Li, Deborah Donnell, Robert R. Bies, Craig W. Hendrix +16 more

Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial

UNC Libraries(2025)10.17615/9zee-gb05

N/A

0DataRank · unranked

0 citations

Beatriz Grinsztejn, Mark A. Marzinke, Brett Hanscom, Alex R. Rinehart, Susan H. Eshleman +26 more

James F. Rooney

Indexed papers

Top data-sharing exemplar

Papers